SPDR S&P Biotech ETF $XBI Shares Purchased by Clearbridge Investments LLC

Clearbridge Investments LLC lifted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 9.8% in the fourth quarter, Holdings Channel reports. The firm owned 395,991 shares of the exchange traded fund’s stock after acquiring an additional 35,483 shares during the period. Clearbridge Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $48,283,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. lifted its position in SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after acquiring an additional 4,411 shares during the period. Ashton Thomas Private Wealth LLC acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $417,000. Banque Pictet & Cie SA lifted its position in SPDR S&P Biotech ETF by 24.1% during the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock worth $7,910,000 after acquiring an additional 12,595 shares during the period. Apella Capital LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $490,000. Finally, PNC Financial Services Group Inc. lifted its position in SPDR S&P Biotech ETF by 60.9% during the 3rd quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock worth $7,067,000 after acquiring an additional 26,705 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.2%

SPDR S&P Biotech ETF stock opened at $128.43 on Tuesday. SPDR S&P Biotech ETF has a twelve month low of $80.90 and a twelve month high of $139.19. The stock has a 50 day moving average of $131.99 and a two-hundred day moving average of $126.74. The stock has a market capitalization of $8.19 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.